Carregant...

Development and characterization of novel potent and stable inhibitors of endopeptidase EC 3.4.24.15.

Solid-phase synthesis was used to prepare a series of modifications to the selective and potent inhibitor of endopeptidase EC 3.4.24.15 (EP24.15), N-[1(R, S)-carboxy-3-phenylpropyl]-Ala-Ala-Tyr-p-aminobenzoate (cFP), which is degraded at the Ala-Tyr bond, thus severely limiting its utility in vivo....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shrimpton, C N, Abbenante, G, Lew, R A, Smith, I
Format: Artigo
Idioma:Inglês
Publicat: 2000
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1220764/
https://ncbi.nlm.nih.gov/pubmed/10620512
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!